Published on Friday November 12, 2021

We are working on the following new projects:

  • We signed a new contract for BE trial with our Indian long-term sponsor.
  • We signed a contract for a new phase III clinical trial of Nimesulid.

We are happy to reach the following milestones in our projects:

  • The first 4 sites were initiated in the trial with the original drug for the patients with chronic myeloid leukemia.
  • The site was initiated in the Dalteparin trial.
  • Scientific Department employees finished training “Modern requirements for the development and registration of herbal medicines and homeopathic medicines” in the FSBI «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation.